Related Experiment Video
Updated: Aug 6, 2026

Preparation of Pooled Human Platelet Lysate (pHPL) as an Efficient Supplement for Animal Serum-Free Human Stem Cell Cultures
Published on: October 30, 2009
Lyophilized platelets: continued development
1Department of Pathology & Laboratory Medicine, East Carolina University, Greenville, NC, USA.
Freeze-dried platelets, stabilized with paraformaldehyde, retain their structure and function. These lyophilized platelets show hemostatic efficacy in vivo and minimal risk, supporting clinical trials.
Area of Science:
- Hematology
- Biotechnology
- Biomaterials
Background:
- Platelets are crucial for hemostasis.
- Current platelet storage methods have limitations.
- Lyophilization offers a potential alternative for platelet preservation.
Purpose of the Study:
- To evaluate the functionality and safety of freeze-dried platelets.
- To assess the hemostatic efficacy of lyophilized platelets in vivo.
- To investigate the immunogenic potential and clearance of repeated infusions.
Main Methods:
- Platelets were stabilized with paraformaldehyde and freeze-dried.
- Morphological integrity was assessed post-rehydration.
- In vitro adhesion and procoagulant assays were performed.
- In vivo hemostatic efficacy was tested in thrombocytopenic animal models.
- Receptor binding studies (GpIb, GpIIbIIIa) were conducted.
- Repeated infusion safety was evaluated in canine models.
Main Results:
- Rehydrated platelets were morphologically intact.
- Adhesive and procoagulant properties were retained.
- In vitro adhesion and in vivo hemostasis were demonstrated.
- GpIb receptor remained intact; GpIIbIIIa was attenuated.
- No cytopenia or accelerated clearance observed after repeated infusions.
Conclusions:
- Freeze-dried platelets maintain essential functions and demonstrate hemostatic efficacy.
- Lyophilized platelets show a low risk of thrombosis and immunogenicity.
- These findings support the progression to clinical trials for freeze-dried platelet applications.
More Related Videos
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024